171 related articles for article (PubMed ID: 27542255)
1. Radiofrequency hyperthermia promotes the therapeutic effects on chemotherapeutic-resistant breast cancer when combined with heat shock protein promoter-controlled HSV-TK gene therapy: Toward imaging-guided interventional gene therapy.
Luo J; Wu X; Zhou F; Zhou Y; Huang T; Liu F; Han G; Chen L; Bai W; Wu X; Sun J; Yang X
Oncotarget; 2016 Oct; 7(40):65042-65051. PubMed ID: 27542255
[TBL] [Abstract][Full Text] [Related]
2. Non-Small-Cell Lung Cancer: Feasibility of Intratumoral Radiofrequency Hyperthermia-enhanced Herpes Simplex Virus Thymidine Kinase Gene Therapy.
Ji J; Weng Q; Zhang F; Xiong F; Jin Y; Hui J; Song J; Gao J; Chen M; Li Q; Shin D; Yang X
Radiology; 2018 Aug; 288(2):612-620. PubMed ID: 29893649
[TBL] [Abstract][Full Text] [Related]
3. Combined treatment of cholangiocarcinoma with interventional radiofrequency hyperthermia and heat shock protein promoter-mediated HSV-TK gene therapy.
Luo J; Zhou J; Xie F; Zhu Y; Zhou F; Zhang S; Jiang S; He J; Liu J; Wu X; Zhang Y; Sun J; Yang X
Am J Cancer Res; 2018; 8(8):1595-1603. PubMed ID: 30210927
[TBL] [Abstract][Full Text] [Related]
4. Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer.
Isomoto H; Ohtsuru A; Braiden V; Iwamatsu M; Miki F; Kawashita Y; Mizuta Y; Kaneda Y; Kohno S; Yamashita S
Oncol Rep; 2006 Mar; 15(3):629-35. PubMed ID: 16465423
[TBL] [Abstract][Full Text] [Related]
5. Molecular imaging-monitored radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus-thymidine kinase gene therapy for rat orthotopic ovarian cancer.
Li Y; Zhao S; Zhang F; Jin G; Zhou Y; Li P; Shin D; Yang X
Int J Hyperthermia; 2020; 37(1):101-109. PubMed ID: 31969028
[No Abstract] [Full Text] [Related]
6. Combination of PEI-Mn0.5Zn0.5Fe2O4 nanoparticles and pHsp 70-HSV-TK/GCV with magnet-induced heating for treatment of hepatoma.
Tang Q; Lu M; Chen D; Liu P
Int J Nanomedicine; 2015; 10():7129-43. PubMed ID: 26604760
[TBL] [Abstract][Full Text] [Related]
7. Eradication of breast cancer xenografts by hyperthermic suicide gene therapy under the control of the heat shock protein promoter.
Braiden V; Ohtsuru A; Kawashita Y; Miki F; Sawada T; Ito M; Cao Y; Kaneda Y; Koji T; Yamashita S
Hum Gene Ther; 2000 Dec; 11(18):2453-63. PubMed ID: 11119417
[TBL] [Abstract][Full Text] [Related]
8. Epithelial ovarian cancer: feasibility of image-guided intratumoral radiofrequency hyperthermia-enhanced direct gene therapy.
Jin G; Li Y; Zhang F; Li P; Zhao L; Zhou Y; Ji H; Pietrini S; Zhai B; Yang X
Am J Cancer Res; 2019; 9(2):378-389. PubMed ID: 30906635
[TBL] [Abstract][Full Text] [Related]
9. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
10. Cholangiocarcinoma: molecular imaging-guided radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus thymidine kinase gene therapy.
Jin Y; Gao J; Weng Q; Xiong F; Gu S; Shivaram G; Zhang F; Yang X
Am J Cancer Res; 2018; 8(3):502-513. PubMed ID: 29637004
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency hyperthermia-enhanced herpes simplex virus-thymidine kinase/ganciclovir direct intratumoral gene therapy of hepatocellular carcinoma.
Wang J; Shi Y; Bai Z; Li Y; Qiu L; Johnson G; Zhang F; Yang X
Int J Hyperthermia; 2017 Mar; 33(2):170-177. PubMed ID: 27569361
[TBL] [Abstract][Full Text] [Related]
12. Orthotopic hepatic cancer: radiofrequency hyperthermia-enhanced intratumoral herpes simplex virus-thymidine kinase gene therapy.
Xiong F; Zhang F; Jin Y; Weng Q; Song J; Zhou G; Shin D; Zheng C; Yang X
Oncotarget; 2018 Mar; 9(18):14099-14108. PubMed ID: 29581830
[TBL] [Abstract][Full Text] [Related]
13. Positive selection of gene-modified cells increases the efficacy of pancreatic cancer suicide gene therapy.
Martinez-Quintanilla J; Cascallo M; Gros A; Fillat C; Alemany R
Mol Cancer Ther; 2009 Nov; 8(11):3098-107. PubMed ID: 19887556
[TBL] [Abstract][Full Text] [Related]
14. [HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter].
Wang WD; Chen ZT; Li DZ; Duan YZ; Wang ZX; Cao ZH
Ai Zheng; 2004 Jul; 23(7):788-93. PubMed ID: 15248913
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors.
Dong D; Dubeau L; Bading J; Nguyen K; Luna M; Yu H; Gazit-Bornstein G; Gordon EM; Gomer C; Hall FL; Gambhir SS; Lee AS
Hum Gene Ther; 2004 Jun; 15(6):553-61. PubMed ID: 15212714
[TBL] [Abstract][Full Text] [Related]
16. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effects of cytosine deaminase and thymidine kinase fusion suicide gene under the control of mdr1 promoter in mdr1 positive leukemia cells.
Wang X; Ji C; Ma D; Zhao J; Hou M; Yu H; Zang S
Leuk Lymphoma; 2007 Aug; 48(8):1600-9. PubMed ID: 17701592
[TBL] [Abstract][Full Text] [Related]
18. Co-expression of herpes simplex virus thymidine kinase and Escherichia coli nitroreductase by an hTERT-driven adenovirus vector in breast cancer cells results in additive anti-tumor effects.
Yu B; Zhang Y; Zhan Y; Zha X; Wu Y; Zhang X; Dong Q; Kong W; Yu X
Oncol Rep; 2011 Jul; 26(1):255-64. PubMed ID: 21573500
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral radiofrequency hyperthermia-enhanced direct chemotherapy of pancreatic cancer.
Bai Z; Shi Y; Wang J; Qiu L; Monroe EJ; Teng G; Zhang F; Yang X
Oncotarget; 2017 Jan; 8(2):3591-3599. PubMed ID: 27690303
[TBL] [Abstract][Full Text] [Related]
20. Construction of double suicide genes system controlled by MDR1 promoter with targeted expression in drug-resistant glioma cells.
Zhang Y; Wang CW; Wang ZG; Ma DX; Pan S; Zhu SG; Li F; Wang B
J Neurooncol; 2008 Jan; 86(1):3-11. PubMed ID: 17594053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
